DF
REGN icon

Dunhill Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Dunhill Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.73K Hold
4
– – ﹤0.01% 776
2026
Q1 		$3.1K Hold
4
– – ﹤0.01% 710
2025
Q4 		$2.97K Buy
4
+2
+100% +$1.36K ﹤0.01% 681
2025
Q3 		$1.4K Sell
2
-2
-50% -$1.13K ﹤0.01% 746
2025
Q2 		$2.16K Sell
4
-4
-50% -$2.23K ﹤0.01% 672
2025
Q1 		$4.9K Sell
8
-367
-98% -$252K ﹤0.01% 567
2024
Q4 		$267K Buy
375
+241
+180% +$202K 0.12% 69
2024
Q3 		$141K Buy
134
+10
+8% +$11.1K 0.07% 98
2024
Q2 		$130K Buy
124
+112
+933% +$109K 0.08% 92
2024
Q1 		$11.2K Buy
12
+2
+20% +$1.9K 0.01% 220
2023
Q4 		$8.84K Buy
+10
New +$8.23K 0.01% 222

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Dunhill Financial's REGN Position: Q2 2026 in Review

Dunhill Financial held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 4 shares worth $2.73K. The position accounts for ﹤0.01% of the portfolio, ranked #776.

Dunhill Financial first reported a position in REGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $267K in Q4 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Dunhill Financial held 4 shares of Regeneron Pharmaceuticals worth $2.73K as of Q2 2026.
  • Dunhill Financial left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #776 holding.
  • Dunhill Financial first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Dunhill Financial's Regeneron Pharmaceuticals position peaked at $267K in Q4 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.